ClinicalTrials.gov
public full text
Public Domain
Terlipressin Administration in Septic Shock Refractory to Catecholamines
terlipressin is given to refractory septic shock patients who do not respond to noradrenalin in Israel and Europe. It is given by bolus injection. we attempt to investigate weather it is better to give it by continuous drip and avoid abrupt changes in BP and heart function
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Noradrenalin vs Terlipressin in Hepatorenal Syndrome#1008908
- Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock.#888173
- Terlipressin in paediatric hepatorenal syndrome-acute kidney injury (HRS-AKI)#462543
- AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock#813579
- Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1#893273
Record · ID 904525
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive